Approval · Notice of Compliance 28475 · 2022
SPRAVATO: Notice of Compliance 28475
Issued June 28, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 28475
- Date
- June 28, 2022
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to the Product Monograph (PM) and convert the PM to the new 2020 format.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SPRAVATO | Not yet assigned | — |
Medicinal ingredients
- ESKETAMINE HYDROCHLORIDE 28 MG per SPR